Codon 89 polymorphism in the human 5α-reductase gene in primary breast cancer

British Journal of Cancer

Volumn 84, Issue 6, 2001, Pages 760-767

  Scorilas, A ^a,b   Bharaj, B ^a   Giai, M ^c   Diamandis, E P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

5 reductase; Androgens; Androgens and breast cancer; Breast cancer; Breast cancer prognosis; Hormones and cancer; Point mutations; Polymorphisms; PSA; SRD5A2

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CODON; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CODON; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; SURVIVAL ANALYSIS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0035937365     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1681     Document Type: Article

References (58)

1. Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5-alpha reductase during prostate cancer progression
2. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors and site of relapse in primary breast cancer
3. Relationships between cathepsin D, PS2 protein and hormonal receptors in breast cancer cytosols: Inconsistency with their established prognostic significance
4. Hormonal regulation of the human pepsinogen C gene in breast cancer cells: Identification of a cis-acting element mediating its induction by androgens, glucocorticoids and progesterone
5. Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer
6. Rapid and accurate determination of CAG repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis
7. Rapid sequencing of the p53 gene with a new automated sequencer
8. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer
9. Histological grading and prognosis in breast cancer
10. Androgen receptors in breast cancer
11. Prostate cancer. An overview of an increasing dilemma
12. DNA flow cytometry and prognostic factors in 1131 frozen breast cancer specimens
13. Ultrasensitive detection of prostate specific antigen by a new time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: Potential applications in prostate and breast cancers
14. Prognostic value of pS2 and cathepsin D in 710 human primary breast tumors: Multivariate analysis
15. The effect of finesteride in men with benign prostate hyperplasia
16. Androgens in breast cancer. A typical endometrial hyperplasia and breast cancer in married pre-menopausal women
17. Androgens in breast cancer. II Endrometrial adenocarcinoma and breast cancer in married post menopausal women
18. Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer
19. Expression of the PIP/GCDFP-15 gene and survival in breast cancer
20. Prostate-specific antigen and gross cystic disease fluid protein- 15 are co-expressed in androgen receptorpositive breast tumors
21. Testosterone in breast fluid
22. A polymorphism of the 5-alpha reductase gene and its association with prostate cancer: A case control analysis
23. Nonparametric estimation from incomplete observations
24. The role of estrogens and progestagens in the epidemiology and prevention of breast cancer
25. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters
26. Structure of human type II 5 alpha reductase gene
27. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features
28. Protein measurement with folin-phenol reagent
29. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
30. Down-regulation of prostate specific antigen (PSA)and human glandular kallikrein 2 (hK2) in malignant vs non-malignant prostatic tissue
31. A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase
32. Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II
33. Estimates of the worldwide mortality from 25 cancers in 1990
34. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues
35. Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk
36. Prognostic significance of steroid hormone receptor and histopathological characterization of human breast cancer
37. 5 Alpha reductase activity and risk of prostate cancer among Japanese and US whites and black males
38. The attraction of proteins for small molecules and ions
39. Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: An independent favorable prognostic factor in node-positive patients
40. Determination of C-myc amplification and overexpression in breast cancer patients. Evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathologic characteristics using univariate and multivariate analysis
41. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy
42. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer
43. Pradoxical effects associated with supra-normal urinary testosterone excretion in pre-menopausal women with breast cancer: Increased risk of post mastectomy recurrence and higher remission rate after ovariectomy
44. Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast
45. Intratumor amount of sex steroids in elderly breast cancer patients. An approach to the biological characterization of mammary tumors in the elderly
46. Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlation to prognostic factors and the predictive value for effect of adjuvant tamoxifen treatment
47. New hormone related markers of high risk to breast cancer
48. Aromatase, 17-betahydroxysteroid dehydrogenase and intratissular concentrations in cancerous and normal glandular breast tissue in postmenopausal women
49. Codon 89 polymorphism of the human 5-alpha steroid reductase type II gene
50. Pepsinogen C is a new prognostic marker in primary breast cancer
51. Natural mutagenesis study of human steroid 5-alpha reductase 2 isozyme
52. Steroid 5-alpha-reductase 2 defiency
53. Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer
54. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue
55. Prognostic value of prostate specific antigen for women with breast cancer; a large United States cohort study
56. Steroid hormone regulation of prostate specific antigen gene expression in breast cancer
57. The nanomer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation